Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Debt Ratio (2016 - 2025)

Guided Therapeutics' Debt Ratio history spans 14 years, with the latest figure at 0.12 for Q3 2025.

  • For Q3 2025, Debt Ratio fell 87.37% year-over-year to 0.12; the TTM value through Sep 2025 reached 0.12, down 87.37%, while the annual FY2024 figure was 0.12, N/A changed from the prior year.
  • Debt Ratio for Q3 2025 was 0.12 at Guided Therapeutics, up from 0.1 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.95 in Q2 2024 and bottomed at 0.01 in Q3 2022.
  • The 4-year median for Debt Ratio is 0.12 (2025), against an average of 0.28.
  • The largest annual shift saw Debt Ratio plummeted 98.64% in 2021 before it surged 1244.73% in 2022.
  • A 4-year view of Debt Ratio shows it stood at 0.33 in 2021, then plummeted by 91.09% to 0.03 in 2022, then surged by 303.04% to 0.12 in 2024, then fell by 0.11% to 0.12 in 2025.
  • Per Business Quant, the three most recent readings for GTHP's Debt Ratio are 0.12 (Q3 2025), 0.1 (Q2 2025), and 0.11 (Q1 2025).